DEA Archived Press Releases

Press Releases before January 20, 2025
400 Results - Showing 291 to 300
PRESS RELEASE

Man Indicted for Taking Controlled Substances from Kansas Hospital

KANSAS CITY, Kan. – A federal grand jury in Kansas returned an indictment charging an Overland Park, Kansas, man on two counts of tampering with a consumer product, one count of possession of fentanyl by deception and subterfuge, and one count of possession of hydromorphone by deception and subterfuge. According...
PRESS RELEASE

Federal Court Orders Tampa Pharmacy to Close in Case Alleging Unlawful Opioid Distribution

MIAMI - A federal court in Florida ordered a Tampa-area pharmacy shut down and prohibited two of its employees from ever owning, managing or operating any business where controlled substances are dispensed. Pursuant to an agreed consent judgment and permanent injunction filed in U.S. District Court for the Middle District...
PRESS RELEASE

DEA Holds National Prescription Drug Take Back Day to Turn the Tide Against the U.S. Opioid Epidemic

DALLAS– The Drug Enforcement Administration will host its 21st National Prescription Drug Take Back Day on Saturday, October 23 from 10 a.m. to 2 p.m. This event offers free and anonymous disposal of unneeded medications at more than 4,000 local drop-off locations nationwide. According to a report published by the...
PRESS RELEASE

DEA Holds National Prescription Drug Take Back Day to Turn the Tide Against the U.S. Opioid Epidemic

NEW ORLEANS – The Drug Enforcement Administration will host its 21st National Prescription Drug Take Back Day on Saturday, October 23 from 10 a.m. to 2 p.m. This event offers free and anonymous disposal of unneeded medications at more than 4,000 local drop-off locations nationwide. According to a report published...
PRESS RELEASE

DEA Holds National Prescription Drug Take Back Day to Turn the Tide Against the U.S. Opioid Epidemic

OMAHA, Neb. – The Drug Enforcement Administration will host its 21st National Prescription Drug Take Back Day on Saturday, October 23, from 10 a.m. to 2 p.m. This event offers free and anonymous disposal of unneeded medications at more than 4,000 local drop-off locations nationwide. According to a report published...
PRESS RELEASE

DEA Holds National Prescription Drug Take Back Day to Turn the Tide Against the U.S. Opioid Epidemic

SAN DIEGO - The Drug Enforcement Administration will host its 21st National Prescription Drug Take Back Day on Saturday, October 23 from 10 a.m. to 2 p.m. This event offers free and anonymous disposal of unneeded medications at more than 4,000 local drop-off locations nationwide. According to a report published...
PRESS RELEASE

Texas Physician Found Guilty for Unlawfully Prescribing Over 1.3 Million Doses of Opioids

HOUSTON - A federal jury convicted a Houston-area physician for unlawfully prescribing more than 1.3 million doses of opioids. According to court documents and evidence presented at trial, Parvez Qureshi, 56, of Houston, Texas, a medical doctor, conspired to and did unlawfully prescribe controlled substances from 2014 through February 2016...
PRESS RELEASE

National Leader of Pagan’s Outlaw Motorcycle Gang Sentenced

NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson and Acting U.S. Attorney for the District of New Jersey Rachael A. Honig announced a Suffolk County, New York, man was sentenced today to 33 months in prison for illegally possessing a...
PRESS RELEASE

Cumberland County Man Admits Role in Conspiracy to Distribute Fentanyl

NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson and Acting U.S. Attorney for the District of New Jersey Rachael A. Honig announced a Cumberland County, New Jersey, man today admitted conspiring to distribute and possessing with intent to distribute 400...
PRESS RELEASE

Creve Coeur Pharmacy and Owner to Pay $1.4 Million for Ignoring Signs of Illegal Drug Prescriptions

ST. LOUIS – Olive Street Pharmacy, LLC, and pharmacy technician Irina Shlafshteyn, agreed to pay $1,507,808.50 to resolve a civil complaint bringing claims under the False Claims Act and Controlled Substances Act related to the unlawful dispensing of controlled substances, including some that were submitted to Medicaid or Medicare for...